| ACE | angiotensin-converting enzyme |
| ACE2 | angiotensin-converting enzyme 2 |
| ACEI | angiotensin-converting enzyme inhibitors |
| AChE | acetylcholinesterase |
| AD | Alzheimer’s disease |
| ALS | amyotrophic lateral sclerosis |
| Ang II | angiotensin II |
| Ang-(1-7) | angiotensin-(1-7) |
| ApoE | apolipoprotein E |
| ARBs | Angiotensin II type 1 (AT1) receptor blockers |
| BBB | blood-brain barrier |
| BDNF | brain-derived neurotrophic factor |
| ChAT | choline acetyltransferase |
| CI | confidence interval |
| CNS | central nervous system |
| COPD | chronic obstructive pulmonary disease |
| COVID-19 | coronavirus disease 2019 |
| CSF | cerebrospinal fluid |
| GM-CSF | granulocyte macrophage-colony stimulating factor |
| HCV | hepatitis C virus |
| HiPSCs | human-induced pluripotent stem cells |
| IFN | interferon |
| IL-1β | interleukin-1β |
| IL-2 | interleukin-2 |
| IL-6 | interleukin-6 |
| IL-10 | interleukin-10 |
| IP-10 | interferon-γ-inducible protein 10 |
| HIV | human immunodeficiency virus |
| HSV | herpes simplex virus |
| mACE2 | membrane-bound ACE2 |
| MCP-1 | monocyte chemoattractant protein-1 |
| MMSE | Mini-Mental State Examination |
| NPI | Neuropsychiatric Inventory |
| PD | Parkinson’s disease |
| PET | positron emission tomography |
| NLRP3 | NLR family pyrin domain-containing protein 3 |
| OR | odds ratio |
| ORF3a | open reading frame 3a |
| RCD | rapid cognitive decline |
| ROS | reactive oxygen species |
| sACE2 | soluble ACE2 |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| TNF-α | tumor necrosis factor α |